Published in Drug Week, May 13th, 2005
Hot flashes occur in up to 85% of menopausal women.
"The completion of our 483-patient Bio-E-Gel trial brings us closer to filing a new drug application (NDA) and reaching our goal of commercializing this important new therapy," said Stephen M. Simes, president and chief executive officer of BioSante. "We are confident in Bio-E-Gel's potential to help menopausal women better manage...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.